Evidence map›Paper›PMID 36973955›Full record

ArticleClinical and translational allergy2023

Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs.

Torsten Zuberbier, Lisa A Beck, Anna Bedbrook, Marjolein de Bruin-Weller, Jean Bousquet, Michael Cork, Nikolaos Douladiris, Norito Katoh, Charlotte G Mortz, Thomas Werfel and 6 more

Full text read
In one paragraph

Article in Clinical and translational allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Torsten ZuberbierInstitute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-1466-8875
Lisa A BeckUniversity of Rochester Medical Center, Rochester, New York, USA.
Anna BedbrookARIA, Montpellier, France.
Marjolein de Bruin-WellerDepartment of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
Jean BousquetInstitute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-4061-4766
Michael CorkSheffield Dermatology Research, IICD, University of Sheffield, Sheffield, UK.
Nikolaos DouladirisAllergy Department, 2nd Paediatric Clinic, National & Kapodistrian University of Athens, Athens, Greece.
Norito KatohDepartment of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Charlotte G MortzDepartment of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense C, Denmark.
Thomas WerfelDivision of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
Francuzik WojciechDivision of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Andreas WollenbergDepartment of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany.
Kristina SiemensDepartment of Women and Children's Health, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Katarina StevanovicInstitute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Margitta WormDivision of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
AD-ICPs Working Group

Funding

Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD PatientsU01AI152011 · NIAID · UNIVERSITY OF ROCHESTER · PI Lisa Ann Beck · 2020 to 2026
$3.2M
Global Allergy and Asthma European NetworkNIAID NIH HHS U01 AI152011
6 · The paper itself

Abstract

backgroundGA

methodsThe GA

resultsHere we discuss the unmet needs in AD, the methodology for devising an AD-ICP and the ICP action plan.

conclusionThe GA

Indexed as

atopic dermatitiseczemaguidanceintegrated care pathways (ICPs)multidisciplinarypreventiontreatment

Identifiers

PMID36973955
PMCPMC10040953

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.